JF
ORMP icon

Jump Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

Jump Financial’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,100
Closed -$234K – 1911
2022
Q3 		$234K Sell
36,100
-1,301
-3% -$10.5K 0.01% 1274
2022
Q2 		$171K Buy
37,401
+2,601
+7% +$13.9K 0.01% 1346
2022
Q1 		$301K Buy
34,800
+10,594
+44% +$109K 0.01% 1068
2021
Q4 		$346K Buy
+24,206
New +$506K 0.02% 817

Other funds holding ORMP

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Jump Financial's ORMP Position: Q4 2022 in Review

Jump Financial sold out of Oramed Pharmaceuticals (ORMP) in Q4 2022, closing a stake of 36,100 shares — an estimated $234K sold.

Jump Financial first reported a position in ORMP in Q4 2021 and held it in 4 quarters. The position peaked at $346K in Q4 2021. 77 funds tracked by Wall St. Rank hold ORMP as of Q4 2022.

  • Jump Financial reported no remaining Oramed Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Jump Financial sold 36,100 Oramed Pharmaceuticals shares in Q4 2022, an estimated $234K.
  • Jump Financial first reported a position in Oramed Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Jump Financial's Oramed Pharmaceuticals position peaked at $346K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q4 2022.

Based on Jump Financial's 13F filing for Q4 2022, filed 14 Feb 2023.